ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.526,27
1,51%
S&P 500
5.099,96
1,02%
US Dollar vs BRL
5,1163
0,00%
Bitcoin
63.537,14
0,20%
Brent Oil
88,165
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Disc Medicine Inc (IRON)

  7. Disc Medicine Inc (IRON) Notícias

IRON

Disc Medicine (IRON)

Disc Medicine Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IRON
DataHoraFonteTítuloCódigoCompanhia
01/04/202409:00GlobeNewswire Inc.Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)NASDAQ:IRONDisc Medicine Inc
21/03/202409:00GlobeNewswire Inc.Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
06/03/202418:30GlobeNewswire Inc.Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024NASDAQ:IRONDisc Medicine Inc
01/03/202421:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
26/02/202410:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
26/02/202410:30GlobeNewswire Inc.Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial OfficerNASDAQ:IRONDisc Medicine Inc
20/02/202410:30GlobeNewswire Inc.Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney DiseaseNASDAQ:IRONDisc Medicine Inc
15/02/202418:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
13/02/202420:51Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IRONDisc Medicine Inc
09/02/202411:00GlobeNewswire Inc.Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia VeraNASDAQ:IRONDisc Medicine Inc
07/02/202410:00GlobeNewswire Inc.Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating OfficerNASDAQ:IRONDisc Medicine Inc
03/01/202419:00GlobeNewswire Inc.Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IRONDisc Medicine Inc
20/12/202318:30GlobeNewswire Inc.Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory BoardNASDAQ:IRONDisc Medicine Inc
11/12/202322:30GlobeNewswire Inc.Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:IRONDisc Medicine Inc
11/12/202314:00GlobeNewswire Inc.Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:IRONDisc Medicine Inc
07/12/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IRONDisc Medicine Inc
05/12/202318:53Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:IRONDisc Medicine Inc
05/12/202318:51Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IRONDisc Medicine Inc
14/11/202318:44GlobeNewswire Inc.Disc Medicine Announces Grant of US Patent for Methods of Treating Erythropoietic Protoporphyrias with BitopertinNASDAQ:IRONDisc Medicine Inc
13/11/202308:46Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:IRONDisc Medicine Inc
09/11/202310:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRONDisc Medicine Inc
09/11/202310:30GlobeNewswire Inc.Disc Medicine Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
08/11/202318:30GlobeNewswire Inc.Disc Medicine to Participate in Upcoming Investor ConferencesNASDAQ:IRONDisc Medicine Inc
02/11/202310:00GlobeNewswire Inc.Disc Medicine Announces Multiple Presentations Across Portfolio at the 65th American Society of Hematology Annual Meeting and Key Program UpdatesNASDAQ:IRONDisc Medicine Inc
23/10/202310:15GlobeNewswire Inc.Disc Medicine Announces Planned Departure of Chief Financial Officer Joanne BryceNASDAQ:IRONDisc Medicine Inc
03/10/202309:30GlobeNewswire Inc.Disc Medicine Initiates a Phase 1 Study of DISC-3405 (anti-TMPRSS6 mAb) in Healthy VolunteersNASDAQ:IRONDisc Medicine Inc
25/09/202317:56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:IRONDisc Medicine Inc
20/09/202318:18Dow Jones NewsDisc Medicine Polycythemia Vera Treatment MWTX-003 Gets FDA Fast Track DesignationNASDAQ:IRONDisc Medicine Inc
20/09/202317:30GlobeNewswire Inc.Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia VeraNASDAQ:IRONDisc Medicine Inc
11/08/202309:00GlobeNewswire Inc.Disc Medicine Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:IRON

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PDGR3
PDG REALT ON
BOV
ZAMP3
Zamp ON
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
GEPA3
GER PARANAP ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
LUPA3
LUPATECH ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados